A unique binding epitope for salvinorin A, a non-nitrogenous kappa opioid receptor agonist

FEBS Journal

Volumn 273, Issue 9, 2006, Pages 1966-1974

  Kane, Brian E ^a   Nieto, Marcelo J ^b   McCurdy, Christopher R ^b   Ferguson, David M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Chimeric; Kappa opioid; Molecular biology; Mutagenesis; Salvinorin

Indexed keywords

GUANIDINYL NALTRINDOLE; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OPIATE RECEPTOR; SALVINORIN A; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CHIMERA; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG STRUCTURE; LIGAND BINDING; MODEL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING SITES; CELL LINE; CELLS, CULTURED; DITERPENES; EPITOPE MAPPING; EPITOPES; HUMANS; MICE; MUTAGENESIS, SITE-DIRECTED; POINT MUTATION; RATS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; RECOMBINANT FUSION PROTEINS; SALVIA;

EID: 33646271609     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2006.05212.x     Document Type: Article

References (40)

1. Roth BL Baner K Westkaemper R Siebert D Rice KC Steinbert S Ernsberger P Rothman RB 2002 Salvinorin A: a potent naturally occurring nonnitrogenous κ opioid selective agonist Proc Natl Acad Sci USA 99 11934 11939
2. Siebert DJ 1994 Salvia divinorum and salvinorin A: new pharmacologic findings J Ethnopharmacol 43 53 56
3. Valdes LJ III. Diaz JL Paul AG 1983 Ethnopharmacology of Ska Maria Pastora (Salvia divinorum, Epling and Jativa-M.) J Ethnopharmacol 7 287 312
4. McCurdy CR Sufka KJ Warnick JE Nieto MJ 2005 Salvinorin A, a kappa opioid receptor agonist, is an ultrashort acting analgesic International Narcotics Research Conference Abstracts M23
5. Metzger TG Paterlini MG Portoghese PS Ferguson DM 1996 Application of the message-address concept to the docking of naltrexone and selective naltrexone-derived opioid antagonists into opioid receptor models Neurochem Res 21 1287 1294
6. Pogozheva ID Lomize AL Mosberg HI 1998 Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints Biophys J 75 612 634
7. Aikopta I Loew GH 1996 A 3D model of the δ opioid receptor and ligand-receptor complexes Protein Eng 9 573 583
8. Strahs D Weinstein H 1997 Comparative modeling and molecular dynamics studies of the δ, κ and μ opioid receptors Protein Eng 10 1019 1038
9. McFadyen I Metzger T Subramanian G Poda G Jorvig E Ferguson DM 2002 Molecular modeling of opioid receptor-ligand complexes Prog Med Chem 40 107 135
10. Lin CE Take MO Pi AE Portoghese PS 1993 Synthesis and κ opioid antagonist selectivity of a norbinaltorphimine congener. Identification of the address moiety required for κ antagonist activity J Med Chem 36 2412 2415
11. Hjorth SA Thirstrup K Grandy DK Schwartz TW 1995 Analysis of selective binding epitopes for the κ-opioid receptor antagonist nor-binaltorphimine Mol Pharmacol 47 1089 1094
12. Thirstrup K Hjorth SA Scwartz TW 1996 Investigation of the binding pocket in the kappa opioid receptor by a combination of alanine substitutions and steric hindrance mutagenesis International Narcotics Research Conference Abstracts M30
13. Jones RM Hjorth SA Schwartz TW Portoghese PS 1998 Mutational evidence for a common kappa antagonist binding pocket in the wild-type kappa and mutant mu[K303E] opioid receptors J Med Chem 41 4911 4914
14. Larson DL Jones RJ Schwartz TW Hjorth SA Portoghese PS 2000 Binding of norbinaltorphimine (norBNI) congeners to wild-type and mutant mu and kappa opioid receptors: molecular recognition loci for the pharmacophore and address components of kappa antagonists J Med Chem 43 1573 1576
15. Stevens WC Jones RM Subramanian G Metzger TG Ferguson DM Portoghese PS 2000 Potent and selective indolomorphinan antagonists of the kappa-opioid receptor J Med Chem 43 2759 2769
16. Metzger TG Paterlini MG Ferguson DM Portoghese PS 2001 Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the 'address' recognition locus J Med Chem 44 857 862
17. 3H] U-69593 a highly selective ligand for the opioid kappa receptor Eur J Pharmacol 109 281 284
18. Subramanian G Paterlini MG Larson DL Portoghese PS Ferguson DM 1998 Conformational analysis and automated receptor docking of selective arylacetamide-based kappa-opioid agonists J Med Chem 41 4777 4789
19. Kong H Raynor K Reisine T 1994 Amino acids in the cloned mouse kappa receptor that are necessary for high affinity agonist binding but not antagonist binding Regul Peptide 54 155 156
20. Wang JB Johnson PS Wu JM Wang WF Uhl GR 1994 Human κ-opiate receptor second extracellular loop elevates dynorphins affinity for μ/κ chimeras J Biol Chem 269 25966 25969
21. Kong H Raynor K Yano H Takeda J Bell GI Reisine T 1994 Agonists and antagonists bind to different domains of the kappa opioid receptor Proc Natl Acad Sci USA 91 8042 8046
22. Xue JC Chen C Zhu J Kunapuli S DeRiel JK Yu L Liu-Chen LY 1994 Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor J Biol Chem 269 30195 30199
23. Paterlini MG Portoghese PS Ferguson DM 1997 Molecular simulation of dynorphin-A (1-10) binding to extracellular loop II of the κ-opioid receptor J Med Chem 40 3254 3262
24. Ferguson DM Kramer S Metzger TG Law PY Portoghese PS 2000 Isosteric replacement of acidic with neutral residues in extracellular loop-2 of the -opioid receptor does not affect dynorphin A (1-13) affinity and function J Med Chem 43 1251 1252
25. Coward P Wada HG Falk MS Chan SDH Meng F Akil H Conklin BR 1998 Controlling signaling with a specifically designed G(i) -coupled receptor Proc Natl Acad Sci USA 95 352 357
26. Lavecchia A Greco G Novellino E Vittorio F Ronsisvalle G 2000 Modeling of κ-opioid receptor/agonists interactions using pharmacophore-based and docking simulations J Med Chem 43 2124 2134
27. Yan F Mosier PD Westkaemper RB Stewart J Zjawiony JK Vortherms TA Sheffler DJ Roth BL 2005 Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to κ-opioid receptors Biochem 44 8643 8651
28. Beguin C Richards MR Wang Y Chen T Liu-Chen LY Ma Z Lee DYW Carlezon WA Jr. Cohen BM 2005 Synthesis and in vitro pharmacological evaluation of salvinorin A analogues modified at C (2) Bioorg Med Chem Lett 15 2761 2765
29. Harding WW Tidgewell K Byrd N Cobb H Dersch CM Butelman ER Rothman RB Prisinzano TE 2005 Neoclerodane diterpenes as a novel scaffold for μ-opioid receptor ligands J Med Chem 48 4765 4771
30. Minami M Onogi T Nakagawa T Katao Y Aoki Y Katsumata S Satoh M 1995 DAMGO, a μ-opioid receptor selective ligand, distinguishes between μ- and κ-opioid receptors at a different region from that for the distinction between μ- and δ-opioid receptors FEBS Lett 364 23 27
31. Meng F Hoversten MT Thompson RC Taylor L Watson SJ Akil H 1995 A chimeric study of the molecular basis of affinity and selectivity of the kappa and the delta opioid receptors. Potential role of extracellular domains J Biol Chem 270 12730 12736
32. Meng F Ueda Y Hoversten MT Thompson RC Taylor L Watson SJ Akil H 1996 Mapping the receptor domains critical for the binding selectivity of delta-opioid receptor ligands Eur J Pharmacol 311 285 292
33. Zhu J Xue JC Law PY Claude PA Luo LY Yin J Chen C Liu-Chen LY 1996 The region in the mu opioid receptor conferring selectivity for sufentanil over the delta receptor is different from that over the kappa receptor FEBS Lett 384 198 202
34. Metzger TG Ferguson DM 1995 On the role of extracellular loops of opioid receptors in conferring ligand sensitivity FEBS Lett 375 1 4
35. Befort K Tabbara L Bausch S Chavkin C Evans C Kieffer B 1996 The conserved aspartate residue in the third putative transmembrane domain of the δ-opioid receptor is not the anionic counterpart for cationic binding but is a constituent of the receptor binding site Mol Pharmacol 49 216 223
36. Mo Y, Subramanian G Gao J Ferguson DM 2002 Cation-pi interactions: an energy decomposition analysis and its implication in delta-opioid receptor-ligand binding J Am Chem Soc 124 4832 4837
37. Chen C Okayama H 1987 High efficiency transformation of mammalian cells by plasmid DNA Mol Cell Biol 7 2745 2752
38. 50) of an enzymatic reaction Biochem Pharmacol 22 3099 3108
39. Munro TA Rizzacasa MA 2003 Salvinorins D-F, new neoclerodane diterpenoids from Salvia divinorum, and an improved method for isolation of salvinorin A J Nat Prod 66 703 705
40. Ortega A Blount JF Manchand PS 1982 Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum J Chem Soc Perkin Trans 1 2505 2508